Natera, Inc. Common Stock (NTRA) is a publicly traded Healthcare sector company. As of November 17, 2026, NTRA trades at $301.13 with a market cap of $46.27B and a P/E ratio of -296.14. NTRA moved +4.38% today. Year to date, NTRA is +26.00%; over the trailing twelve months it is +41.15%. Its 52-week range spans $125.38 to $437.41. Analyst consensus is strong buy with an average price target of $422.74. Rallies surfaces NTRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
17 analysts cover NTRA: 0 strong buy, 16 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $422.74.
| Metric | Value |
|---|---|
| Price | $301.13 |
| Market Cap | $46.27B |
| P/E Ratio | -296.14 |
| EPS | $-1.35 |
| Dividend Yield | 0.00% |
| 52-Week High | $437.41 |
| 52-Week Low | $125.38 |
| Volume | 17.89K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.71B |
| Net Income | $-192.35M |
| Gross Margin | 0.00% |
17 analysts cover NTRA: 0 strong buy, 16 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $422.74.